Expert Opinion on Drug Metabolism & Toxicology

译名:药物代谢与毒理学专家观点

SCIEJCR Q1中科院3区

3-5

2026

影响因子区间

平台估算

投稿周期

13%

2025

中国作者发文占比

2760 USD;2270 GBP;2610 EUR

费用说明

收费

期刊简介:Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.The Editors welcome:Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.

【译文】关于药物代谢与毒性的专家意见(ISSN 1742-5255 [印刷版],1744-7607 [电子版])是一本MEDLINE索引、同行评审的国际期刊,发表关于ADME-Tox所有方面的综述文章。每篇文章的结构都旨在融入作者对未来发展范围的自身专家意见。编辑们欢迎:涵盖特定药物、药物相互作用、药物类别或其在特定人群中使用相关的代谢、药代动力学和毒理学问题的综述;涉及参与药物代谢、处置和排泄的酶的问题;涉及药物代谢和毒理学研究的技术;获取ADME-Tox数据的新技术。对特定药物的临床、毒理学和药代动力学数据进行评估的药物评估。读者包括制药行业的科学家和管理人员、药理学家、临床毒理学家和相关专业人士。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1742-5255
eISSN
1744-7607
出版频率
双月刊
创刊年份
2005
投稿网址
https://mc.manuscriptcentral.com/eomt
最近更新
2026-04-02 18:16:40
Expert Opinion on Drug Metabolism & Toxicology

指标当前值近三年趋势
JCR分区Q1
暂无
中科院分区3区
暂无
影响因子区间3-5
暂无